FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a medicinal preparation in the form of tablets for prevention and / or treatment of catarrhal, acute respiratory and other infectious-inflammatory diseases of throat and oral cavity, which includes flurbiprofen, cetylpyridinium hydrochloride or cetylpyridinium hydrochloride monohydrate, levomenthol, eucalyptus oil, citric acid or monohydrate of citric acid, pectin, as well as auxiliary substances, including povidone, sucralose, lactose or lactose monohydrate, polysorbate-80, sorbitol, colloidal silicon dioxide, magnesium stearate and natural flavoring agent, with following components content in mg per g: flurbiprofen 7.88-9.63; cetylpyridinium chloride or cetylpyridinium chloride monohydrate 0.90-1.10; levamentol 2.0-5.0; eucalyptus oil 0.50-1.0; pectin 3.0-10.0; citric acid or citric acid monohydrate 5.0-15.0; povidone 15.0-30.0; sucralose 3.0-7.0; lactose or lactose monohydrate 100.0-250.0; polysorbate-80 2.0-4.0; silicon dioxide colloidal 3.0-10.0; magnesium stearate 5.0-10.0; the natural flavor is 5.0-20.0; sorbitol makes up to 1.0 g.
EFFECT: invention provides enhanced therapeutic effect, reduced risk of side effects, reduced length of drug therapy.
1 cl, 14 ex
